Charles M. Rudin - Concepedia

Author

Charles M. Rudin

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

A Rauch, Andrea Rolong, Andreas Rimner, C M Rudin, C Rudin, C. M. RUDIN, C. M. Rudin, C. Rudin, C.M Rudin, C.M. Rudin

1.7K

Publications

85.1K

Citations

131

H-Index

209

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Cornell University Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center Dana-Farber Cancer Institute

About

Charles M. Rudin is an author at Memorial Sloan Kettering Cancer Center specializing in medicine, oncology, and lung cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	78	203	32.4K
2	Health Sciences	20	30	2.9K
3	Engineering	9	9	578
4	Natural Sciences	3	3	234
5	Language Studies	1	1	13

Charles M. Rudin

382

Publications

74.1K

Citations

120

H-Index

Page 1

	Year	Citations
Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer H. Borghaei, L. Paz-Ares, Leora Horn, New England Journal of Medicine	2015	9.3K
Tumor mutational load predicts survival after immunotherapy across multiple cancer types Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari, Nature Genetics Cancer ImmunosurveillanceTumor HeterogeneityMedicineImmunologyPathology	2019	4.2K
Using Multiplexed Assays of Oncogenic Drivers in Lung Cancers to Select Targeted Drugs Mark G. Kris, Bruce E. Johnson, Lynne D. Berry, JAMA	2014	1.7K
<i>STK11/LKB1</i> Mutations and PD-1 Inhibitor Resistance in <i>KRAS</i>-Mutant Lung Adenocarcinoma Ferdinandos Skoulidis, Michael E. Goldberg, Danielle Greenawalt, Cancer Discovery	2018	1.5K
Akt Stimulates Aerobic Glycolysis in Cancer Cells Rebecca Elstrom, Daniel E. Bauer, Monica Buzzai, Cancer Research	2004	1.4K
Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro, New England Journal of Medicine	2012	1.4K
Molecular Determinants of Response to Anti–Programmed Cell Death (PD)-1 and Anti–Programmed Death-Ligand 1 (PD-L1) Blockade in Patients With Non–Small-Cell Lung Cancer Profiled With Targeted Next-Generation Sequencing Hira Rizvi, Francisco Sánchez-Vega, Konnor La, Journal of Clinical Oncology ImmunologyPathologyImmunotherapyTumor BiologyOncology	2018	1.4K
Extracellular Vesicle and Particle Biomarkers Define Multiple Human Cancers Ayuko Hoshino, Han Sang Kim, Linda Bojmar, Cell Tumor BiologyExtracellular VesicleMedicinePathologyExtracellular Microvesicles	2020	1.2K
Genomic Features of Response to Combination Immunotherapy in Patients with Advanced Non-Small-Cell Lung Cancer Matthew D. Hellmann, Tavi Nathanson, Hira Rizvi, Cancer Cell ImmunologyPathologyImmune Cell TherapyImmunotherapyGenomic Features	2018	1.2K
Pneumonitis in Patients Treated With Anti–Programmed Death-1/Programmed Death Ligand 1 Therapy Jarushka Naidoo, Xuan Wang, Kaitlin M. Woo, Journal of Clinical Oncology	2016	1.1K

Page 1